Acotec Scientific (HKG:6669) obtained registration approval for the Microcatheter V-otter from China's National Medical Products Administration, a Wednesday Hong Kong bourse filing said.
Shares of the electric car solutions provider were up over 2% in Thursday afternoon trading.
V-otter is indicated for percutaneous interventional procedures in peripheral and coronary vasculature to deliver diagnostic, embolic, or therapeutic materials on reaching the target site.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.